comprehensive -WSS

comprehensive

author：entertainment 2025-09-29 01:38:04 - browse：3143

U.S. Sen. Bernie Sanders sets his hands on two chairs as two people set up a board displaying a "price of drugs" chart behind him — politics coverage from STAT — Sen. Bernie Sanders has used his leadership of a Senate committee to pressure drugmakers to lower their prices. Kevin Dietsch/Getty Images

WASHINGTON — Bernie Sanders is figuring out just how far bullying drugmakers can take him.

For more than a year, Sanders has used his perch atop the Senate health committee to haul the CEOs of pharmaceutical companies that make insulin, vaccines, and more before the panel with progressively more ambitious demands related to their pricing. After a few victories he’s claimed — experts say some credit is deserved, but the full story is a bit more complicated — he’s now progressed to demanding that Novo Nordisk cut its price for its novel, wildly popular diabetes and weight-loss drugs.

Sanders (I-Vt.) is testing the limits of the powers of a Senate chairman with little hope of advancing his policy agenda legislatively. He’s threatened subpoenas, held a prominent nominee hostage, and initiated investigations to get his way. It’s a sharp departure from the modest, bipartisan ambitions that more disciplined, discreet leaders of the committee have taken in years past, and sets the bar for how much can be accomplished using the full extent of the bully pulpit.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Black vets could get higher VA benefits if race not used in lung test

Wikipedia

WSS

Novel spinal cord stimulator treats paralysis without surgery

Eight reasons why you should get an updated Covid vaccine

Sepsis can kill a child within hours. Here's how hospitals are fighting back

UnitedHealth’s Q3 profit jumps as medical costs rise more slowly

Warren pushes Witty on UnitedHealth's control over physicians

BIO to announce reorganization, senior leaders expected to depart

hotspot

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+.

explore

Trump demands the U.S. pay no more for drugs than other countries … again

Sepsis can kill a child within hours. Here's how hospitals are fighting back

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

GSK’s asthma push continues as drug succeeds in Phase 3 trials

Drug repurposing or repositioning? The language matters

Medicare to cover more brain scans related to Alzheimer’s drugs

Psychedelics group wrestles with new pharma identity

Has Bernie Sanders reached the limit of his pharma bullying effort?

State Dept. review finds Biden bears some blame for Afghanistan failures

AltruBio raises $225 million to develop ulcerative colitis drug

leisure time

Akero's treatment for NASH falls short in cirrhosis study

Female surgeons have lower rates of long

Welsh Carson private equity firm escapes from FTC antitrust case

Primary care doctor shortage won't be solved by free med school tuition

How a small hospital in rural Puerto Rico survived Hurricane Maria

Life sciences deals on track to hit lowest point since 2017

leisure time

focus

Wikipedia

leisure time